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Abstract Brain-resident macrophages (microglia) are key
cellular elements in the preservation of tissue integrity. On
the other hand, they can also contribute to the development
of pathological events by causing an extensive and
inappropriate inflammatory response. A growing number
of reports indicate the involvement of nucleotides in the
control of microglial functions. With this study on P2Y
receptors in rat microglia, we want to contribute to the
definition of their expression profile and to the character-
isation of their signalling mechanisms leading to Ca
2+
movements. Endogenous nucleotides, when applied at a
concentration of 100 μM, elicited robust Ca
2+ transients,
thanks to a panel of metabotropic receptors comprising
mainly P2Y2, P2Y6 and P2Y12 subtypes. The involvement
of P2Y12 receptors in Ca
2+ responses induced by adenine
nucleotides was confirmed by the pharmacological and
pertussis toxin sensitivity of the response induced by
adenosine diphosphate (ADP). Beside the G protein
involved, Gi and Gq respectively, adenine and uracil
nucleotides differed also for induction by the latter of a
capacitative Ca
2+ plateau. Moreover, when applied at low
(sub-micromolar) concentrations with a long-lasting chal-
lenge, uracil nucleotides elicited oscillatory Ca
2+ changes
with low frequency of occurrence (≤1 min
−1), sometimes
superimposed to an extracellular Ca
2+-dependent sustained
Ca
2+ rise. We conclude that different patterns of Ca
2+
transients are induced by low (i.e., oscillatory Ca
2+ activity)
compared to high (i.e., fast release followed by sustained
raise) concentrations of nucleotides, which can suggest
different roles played by receptor stimulation depending not
only on the type but also on the concentration of
nucleotides.
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Introduction
Distributed in the central nervous system (CNS) parenchy-
ma in a ramified morphology, microglial cells play a
continuous “resting activity” of surveillance. Signals not
well identified as yet seem to be required to keep microglia
in such a quiescent but alert state. Similarly, signals
resulting from an ongoing acute insult or from a chronic
degenerative condition drive toward or maintain microglia
in a state of cell activation. Synthesis of pro- and anti-
inflammatory cytokines, reactive oxygen species, nitric
oxide, prostaglandins, expression of major histocompatibil-
ity complex (MHC) molecules and re-arrangement of the
ion channel profile are only some of the changes acquired
by activated microglial cells [1–3]. In principle, these newly
acquired functional capabilities would tend to favour
protection and recovery of homeostasis, but in some
instances, control on the overall inflammatory response is
lost and an exacerbation of the pathology takes place.
Participation in the pathogenesis of virtually all acute and
chronic diseases has been suggested for microglia. The
dichotomy of microglia between guardian and potentially
promoter of recovery on one hand and pathogenic cellular
entity on the other hand has drawn interest to the search
for signals driving microglia to beneficial capabilities and
the control of pro-inflammatory and potentially harmful
activities [4, 5].
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e-mail: visentin@iss.itAdenosine triphosphate (ATP) and other nucleotides have
been extensively described as multi-functional agents acting
on neuronal and glial cells. ATP acts as a fast synaptic
neurotransmitter by binding to post-synaptic P2X receptors
in a variety of neuronal cells, in keeping with their wide
distribution predominantly on brain neurons [6]. ATP also
acts on postsynaptic P2Y receptors, modulating voltage-
dependent K
+ and Ca
2+ currents [7, 8]. P2Y receptors were
also described to interfere with N-methyl-D-aspartate
(NMDA) but not with alpha-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid (AMPA) glutamate receptors,
probably by inducing phosphorylation of the receptor
protein [9]. ATP and analogues acting on P2Y receptors
regulate the release of neurotransmitters such as acetyl-
choline, noradrenaline, dopamine, serotonin and gluta-
mate (6 for references) in concert with adenosine.
Also, all glial cell types have been described to react to
ATP and other nucleotides. ATP and analogues were shown
to induce astrocyte proliferation, stellation and increase of
glial fibrillary acidic protein (GFAP) expression, all symp-
toms of astrogliosis [10–12], by stimulating P2Y receptors.
Ca
2+ wave propagation in mechanically or pharmacologi-
cally stimulated cultured astrocytes are known to depend on
the release of ATP and on its effect on adjacent cells [13].
ATP released from stimulated dorsal root ganglia (DRG)
cells was also described to modulate the differentiation and
proliferation of Schwann cells in a in vitro co-culture
system [14]. Recently, we identified ATP and adenosine
diphosphate (ADP) as agents able to control differentiation
and promote migration of oligodendrocyte progenitors by
activation of P2Y1 receptors [15]. A number of different
effects of nucleotides on microglial cells have also been
reported. In microglia, great attention has been dedicated to
P2X ionotropic receptors, and thanks to this, their profile of
expression and a set of functions clearly linked to each
subtype has been delineated. P2X7 receptors, first described
for their pro-inflammatory capabilities due to the induction
of interleukin (IL)-1β and tumour necrosis factor (TNF)-α
release [16, 17], as well as for their cytotoxicity due to
the opening of a large conductance pore [18], are now
considered also as involved in the fine control of microglial
proliferation (Bianco et. al., this issue). A second ionotropic
ATP receptor that we tentatively proposed in microglia as
the P2X4 subtype on the basis of kinetic and pharmaco-
logical properties [19] was then clearly identified in this cell
type, and its role in the induction of tactile peripheral
allodynia following nerve injury was proposed [20]. A
number of studies have addressed the capabilities of
nucleotides to mobilise Ca
2 and to induce the opening of
store-operated Ca
2+ channels by acting on microglial P2Y
receptors [21, 22]. Chemotactic activity induced by ATP
was described to involve P2Y12 receptors [23] while the
release of pro- and anti-inflammatory cytokines was shown
to be under the control of as yet unidentified P2Y receptors
[24–26].
Glial cells are not only targets of nucleotide signalling,
they also are more generally responsible of shaping the
nucleotide signalling system, being also sources of nucleo-
tides and in charge of their degradation. Regardless of the
mechanisms utilised—vesicular, mediated by ATP-binding
cassette (ABC) transportes or through connexin emi-
channels—during Ca
2+ waves propagation, astrocytes re-
lease ATP, which acts as an extracellular messenger in
homo-typical (i.e., astrocyte to astrocyte) and hetero-typical
(i.e., astrocyte to microglia) intercellular communication
[13, 27]. When challenged with the pro-inflammatory factor
lipopolysaccharide (LPS), microglia was described to
release ATP, which, by acting as an autocrine factor,
contributed to processing and release of cytokines IL-β1
and IL-10 [16, 25]. Finally, astrocytes and microglial cells
are deputed to the degradation of extracellular nucleotides
in virtue of the expression of ecto-enzymes ecto-ATPase,
ecto-apyrase and ecto-5′-nucleotidase [28]. Interestingly,
increase of expression of these enzymes after transient fore-
brain ischaemia in the rat was shown to involve mainly
microglia [29], which makes these cells capable of reacting
to the increase of nucleotide release in the attempt to avoid
excessive nucleotide stimulation.
It is known that high doses of nucleotides released by
tissue undergoing stress, cell damage or abnormal death
might act as “danger signals” and cause release of pro-
inflammatory cytokines (IL-1β, TNF-α, IL-6), prostaglan-
dins and reactive oxygen species [30] from immune cells.
On the other hand, it was recently suggested that at lower
doses, nucleotides might play a regulatory role on inflam-
matory reactions aimed at the prevention of tissue damage
[31].
In this study, we focused on P2 metabotropic receptors
in rat microglial cells, and by molecular [reverse transcrip-
tion polymerase chain reaction (RT-PCR)] and functional
(Ca
2+ video imaging) approaches, we characterised expres-
sion profile, functional capability and some aspects of the
pathways involved in receptor activation. By comparing the
effects induced by low versus high concentrations of
metabotropic agonists, we then aimed to depict dependence
on the availability of nucleotides of cytoplasmic Ca
2+
signalling.
Materials and methods
Cell culture
Microglial cells were obtained from the cerebral cortex of
1- to 2-day-old rats [32]. All experiments were carried out
in accordance with directives of the Council of the
606 Purinergic Signalling (2006) 2: 605–617European Communities N. 86/609/CEE. Briefly, after pups
were rendered hypothermic on an ice-cold surface, they
were decapitated. The cerebral cortex was dissected out,
and meninges were removed. The tissue was dissociated by
a two-step procedure comprising enzymatic digestion
followed by mechanical dissociation. Mixed primary
cultures were grown on poly-L-lysine-coated culture flasks
for 7–10 days in Basal Medium Eagle (BME) supple-
mented with 10% endotoxin-free foetal calf serum (FCS),
2 mM glutamine and 100 μgm l
−1 gentamicin (37°C, 5%
CO2). After mild shaking, microglial cells were harvested
and plated on un-coated glass coverslips sealed on home-
made silicon wells at a density of 15 × 10
4 cells/cm
2.T o
further improve the purity of microglial cultures, non-
adhering cells were removed after 20 min by changing the
medium.
RT-PCR
Microglia cells obtained from rat brain at postnatal day 2
were used to extract total ribonucleic acid (RNA) using
Trizol reagent according with the data sheet. Two
micrograms of total RNA were digested for 30 min with
Dnase (Invitrogen) and retro-transcribed using the Super-
Script synthesis system (Life Technologies). Specific
oligonucleotides with similar annealing temperatures were
designed to amplify the following purinergic receptors:
P2Y1 (NM012800.1), P2Y2 (NM017255.1), P2Y4
(NM031680.1), P2Y6 (NM057124.1), P2Y12
(NM022800.1), P2Y13 (NM001002853.1) and P2Y14
(NM133577.1). β-actin (NM031144) was always ampli-
fied as control. Samples were analysed on agarose gel
containing ethidium bromide.
The following primers were used:
P2Y1: forward: 5′-AACAGTACAATCGCCTCGAC-
3′;r e v e r s e :5 ′-TTCGCAGGTACTCATCTGAC-3′.
Band size of 559 bp.
P2Y2:f o r w a r d :5 ′AACGGACGTGAGCATCCAA3′;
reverse: 5′-AGGTGTCGTGGCAGGTGATT-3′. Band
size of 639 bp.
P2Y4: forward: 5′-CCATCCTGTGCCATGACACT-3′;
reverse: 5′-CATAGCTGCTGGAGCTGGTT-3′. Band
size of 418 bp.
P2Y6: forward: 5′-CGGCAGCATCCTGTTCCTCA-3′;
reverse 5′- TGGAGCGCACAGCCAAGTAG-3′. Band
size of 470 bp.
P2Y12: forward: 5′-GGTGTGCCAAGTCACTTCAG;
reverse 5′-ATCAAGGCAGGCGTTCAAGG-3′. Band
size of 598 bp.
P2Y13: forward: 5′-GATGACACAGCTGCTGTTCC-
3′;r e v e r s e :5 ′- TGACTGCTGTGGTGCTCATC-3′.
Band size of 915 bp.
P2Y14:f o r w a r d :5 ′-GCACAAGGCGTCTAAC-
TATGTC-3′; reverse: 5′-CCACATGCCACTTCTC-
CAT TCG-3′. Band size of 692 bp.
β-Actin: forward: 5′-ACCTTCAACACCCCAGCCAT
GTAC G-3′; reverse: 5′-CTGATCCACATCTGCTGG
AAGGTGG-3′. Band size of 698 bp.
Intracellular Ca2+ recording
To record intracellular Ca
2+ we employed the video-
imaging technique with the Ca
2+-sensitive probe Fura-2.
Acetoxymethyl Fura-2 (Fura-2-AM; Molecular Probes,
Leiden, The Netherlands) was dissolved in a solution
containing pluronic acid and dimethylsulfoxide (DMSO)
(1:4 ratio in weight) and then sonicated for 5 min. Micro-
glial cultures were exposed to a solution containing 2.5 μM
Fura-2-AM for 50 min at room temperature to allow cell
loading. To achieve a better hydrolysis of Fura-2-AM, the
cultures were recorded 30 min after washing of the dye.
Silicon wells were removed, and the glass coverslips were
placed in a recording chamber on the stage of an Axiovert
35 inverted microscope (Zeiss, Milan, Italy). Fura-2-loaded
cells were exposed every 1–5 s to the excitation wave-
lengths 340 and 380 nm by means of a monochromator
(Polychrome II, T.I.L.L. Photonics, Planegg, Germany).
The emission light at 510 nm was collected by a digital
camera (Sensicam, PCO, Kelheim, Germany) and recorded
on the hard disk of a PC computer. Recording and analysis
of data were made possible by the Imaging Workbench 5.2
software package (Indec BioSystems, Santa Clara, CA,
USA ). Ratio values were converted to free Ca
2+ concen-
trations by utilising an established equation [33], with
Rmin=0.28, Rmax=6.45, β=4.5.
Unless otherwise stated, the bulk solution had the
following composition (mM): 140 NaCl, 5 KCl, 2.5 CaCl2,
1 MgCl2, 10 D-glucose, 10 HEPES/NaOH (room temper-
ature, pH 7.4, 290 mosmol l
−1). Ca
2+-free solutions were
made by replacing Ca
2+ with an equal amount of Mg
2+.I n
parallel with a perfusion system allowing the change of the
bulk solution of the bath, a local perfusion system was used
(Rapid Solution Changer: RSC 100; Biologic, Grenoble,
France). It consisted of a set of reservoirs containing
different solutions connected to polyethylene tubings with
an internal diameter of 300 μm glued together in a parallel
array from which the flow of solution was made possible by
operating on solenoid valves. Amplitudes of Ca
2+ signals
were calculated as Ca
2+ increase from the pre-application
Ca
2+ level. Peak amplitudes were calculated on single cells,
and their averages were calculated pooling similar
experiments (from a minimum of two experiments for
each condition). Not to underestimate an eventual effect
on sub-populations of cells, we thought it useful to
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experimental values measured in the single cells. The
results obtained with uridine 5'-diphosphate (UDP) were
not statistically different from those obtained with uridine
5'-triphosphate (UTP), which we showed to represent uracil
nucleotides in all figures following Figure 2.
Results
mRNA expression of P2Y receptors
In order to understand which P2Y receptors are expressed
in primary microglial cells, we performed RT-PCR analysis
on purified messenger ribonucleic acid (mRNA) obtained
from primary microglial cells. Specific amplification
profiles are shown in Figure 1. High mRNA expression
was detected for P2Y2,P 2 Y 6, P2Y12 and P2Y14. The weak
band detected for P2Y1 and P2Y4 could not exclude their
presence. Negative control (PCR without Retro transcrip-
tion) was always performed (data not shown).
Effects of endogenous nucleotides on Ca
2+
To contribute to the determination of P2Y receptors
functionally active in our rat microglial cell cultures, we
utilised a number of endogenous nucleotides (ATP, ADP,
UTP, UDP, UDP-glucose). When briefly applied at a high
concentration (100 μM for 20 s), all of them, with the
exception of UDP-glucose, were able to induce a fast Ca
2+
rise followed by a slower phase of recovery in virtually
all microglial cells (Figure 2). The lack of P2Y14 protein
(to be tested when an appropriately validated antibody is
available) or the expression of a protein not functionally
coupled to Ca
2+ release [15] can explain the apparent
incongruence between PCR and Ca
2+ data.
The speed of rise and average Ca
2+ amplitude were
generally unaffected by removal of Ca
2+, with the excep-
tion of a slight decrease of the Ca
2+ concentration reached
when ATP was used (data not shown). Molecular and
functional data are compatible with a P2Y receptor profile
in which the P2Y12 is responsible for adenine nucleotide-
induced Ca
2+ signals and P2Y2 and P2Y6 for UTP- and
UDP-induced Ca
2+ signals. To confirm this description,
especially the role of P2Y12 in Ca
2+ signalling, further
studies testing the pharmacological and pertussis toxin
sensitivity of the ADP response were carried out.
Pharmacological blockade of P2Y receptors
For a pharmacological characterisation of P2Y receptors,
we utilised PPADS and MRS2179. PPADS is a non-
selective but non-universal P2 receptor antagonist. It
efficiently inhibits P2X receptors, but it discriminates
between ADP and UTP responses on P2Y receptors.
Figure 1 Expression pattern of P2Y receptors analysed by reverse
transcription polymerase chain reaction (RT-PCR). (a) In microglial
cells, we found the expression of P2Y2, P2Y6, P2Y12 and P2Y14
receptors. Moreover, a weak amplification of the P2Y1 and P2Y4
receptors was detected. Ethidium-bromide-stained agarose gel shows
RT-PCR products generated from total ribonucleic acid (RNA) of
microglia. (b) In control samples, complementary deoxyribonucleic
acid (cDNA) was reverse transcribed and amplified for β-actin. All
samples were preincubated with DNAse before retro-transcription
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ADP and uracil nucleotides. At a concentration of 100 μM,
PPADS completely inhibited the response to ADP and UTP
in 78% and 18% of the cells (Figure 3a, c), respectively,
and only partially affected the responses induced in the
remaining cells.
MRS2179 can be reliably utilised to detect involvement
of P2Y1 receptors, as we recently confirmed in oligoden-
Figure 2 Adenosine triphosphate (ATP), adenosine diphosphate
((ADP), uridine 5'-triphosphate (UTP) and uridine 5'-diphosphate
(UDP) but not UDP-glucose (P2Y14 agonist) induce intracellular Ca
2+
release in microglia. Microglial cells were challenged with a panel of
naturally occurring nucleotides for 20 s at a concentration of 100 μM.
With the exception of UDP-glucose, nucleotide application caused in
virtually all cells challenged a fast Ca
2+ rise followed by a variable
phase of recovery. The exemplifying traces depict the fact that uracil
nucleotides (UTP and UDP) more consistently induced a Ca
2+ plateau
following the initial peak
Figure 3 Ca
2+ release induced
by nucleotides is differently
affected by pharmacological
inhibitors. Ca
2+ transients in-
duced by adenosine diphosphate
(ADP) and uridine 5'-triphos-
phate (UTP) in the absence of
Ca
2+ were recorded in the ab-
sence or during the application
of P2 antagonists (100 μM, with
2 min of pre-treatment). Each
panel shows frequency distribu-
tion of amplitudes of the Ca
2+
transients recorded in the ab-
sence and presence of the an-
tagonist. (a), (c) PPADS more
efficiently inhibits the ADP-
compared with UTP-induced
Ca
2+ responses (n =6 4 −103).
(b), (d) As expected, the P2Y1
antagonist MRS2179 does not
affect the response to UTP but it
does not inhibit even that to
ADP, outlining the presence of
ADP-sensitive receptors other
than P2Y1 (n =5 9 −164)
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of 100 μM, did not inhibit Ca
2+ responses induced by UTP,
as expected considering that UTP acts on receptors other
than P2Y1 (Figure 3d). However, it was unable to inhibit
even ADP-induced responses (Figure 3b), so confirming
that P2Y1 receptor activation is not appreciably involved in
the induction of Ca
2+movements by ADP in rat microglia.
On the other hand, this observation is in keeping with a role
played by the P2Y12 subtype in ADP-induced Ca
2+
responses.
G protein involvement
As mentioned above, P2Y receptors act by preferentially
binding and activating specific hetero-trimeric G proteins.
Only 10% of microglial cells treated overnight with PTx
were able to show a Ca
2+ response when challenged with
ADP (Figure 4a) while 70% of cells maintained a Ca
2+
response to UTP (Figure 4c) though lacking the capacita-
tive plateau (Figure 4d). PTx-treated cells still responding
to ADP showed a reduced Ca
2+ signal (236±6 nM and
134±13 nM in control and treated cultures, respectively)
while cells still responding to UTP after PTx-treatment
maintained a similar Ca
2+ signal (190±8 nM versus
172±6 nM). Involvement of PTx-sensitive Gi in the
mechanism leading to Ca
2+ rise by ADP further supports
the idea that activation of P2Y12 receptors is responsible for
ADP-induced Ca
2+ movements in microglia. When ATP
was tested in PTx-treated cultures, it elicited a Ca
2+
transient in only a fraction of cells in the absence of Ca
2+,
and it caused small Ca
2+ rises in most cells when Ca
2+ was
present, depicting Ca
2+ influx through ionotropic receptors
(Figure 4b).
Capacitative plateau
According to the above data, a striking difference among
the signals triggered by adenine and uracil nucleotides is
the main G protein involved. A second difference is the
much greater capability of uracil nucleotides to induce,
after the rapid Ca
2+ rise, a sustained Ca
2+ plateau
sometimes appearing as a second and clearly distinguish-
able phenomenon (Figure 2). According to extracellular
Ca
2+ dependence (data not shown) and blockade by
SKF96395 (Figure 5a), it was identified as the capacitative
plateau described in a number of cell types. According to
the canonical description, its induction is due to the opening
of store-operated Ca
2+ (SOC) channels on the plasma
Figure 4 Pertussis toxin com-
pletely inhibits Ca
2+ release in-
duced by adenine nucleotides
but not by uridine 5'-triphos-
phate (UTP). (a), (c) Ca
2+
transients induced by nucleoti-
des (100 μM for 20 s in the
absence of Ca
2+ ) were recorded
from control microglial cultures
and cultures treated overnight
with pertussis toxin (PTx)
50 ng/ml. More than 90% of
PTx-treated cells were unable to
respond to adenosine diphophate
(ADP) (n=107−271) while only
30% did not respond to UTP
(n=98−289). (b) Exemplifying
Ca
2+ traces recorded from PTx-
treated cultures show the lack of
response to ADP, the rare re-
sponse to ATP in the absence of
Ca
2+ and the lower but consis-
tent Ca
2+ transients triggered by
ATP in the presence of Ca
2+,
depicting the lack of sensitivity
to PTx of the ATP-induced
ionotropic response. (d) Exem-
plifying Ca
2+ traces recorded
from PTx-treated cultures
showing UTP-induced Ca
2+
signals with amplitudes compa-
rable with those obtained in
control conditions but without a
sustained plateau
610 Purinergic Signalling (2006) 2: 605–617membrane, following (through a not as yet clearly
determined mechanism) Ca
2+ depletion in the endoplasmic
reticulum. However, this latter mechanism by itself can
unlikely account for the induction of SOC opening in
microglia since ADP and UTP share the same endoplasmic
reticulum (ER) Ca
2+ stores (Figure 5c, d), as depicted by
“cross-desensitisation” experiments, and at the dose used
both agents are able to efficiently induce TER Ca
2+
depletion. A second mechanism triggered by uracil nucleo-
tides but not by ADP and acting in parallel to store
depletion must be involved.
Ca
2+ oscillations induced by low doses of nucleotides
In the attempt to describe P2Y signalling in microglia, we
have so far depicted some peculiar features of adenine
compared with uracil nucleotides, which can cause different
functional roles of P2Y subtypes and of their endogenous
agonists. Then we wanted to investigate the possibility that
differences in the availability of nucleotides for receptor
occupancy and activation could cause qualitatively different
patterns of signalling and, in turn, functional outcomes. A
long-lasting challenge with nucleotides at a concentration of
100 μM (which is a high dose for metabotropic receptors)
caused an initial Ca
2+ peak followed by a maintained Ca
2+
rise only slowly declining in the continuous presence of the
agonist (Figure 6a,b). On the contrary, when using sub-
micromolar concentrations (100–300 nM), a fraction of
cells reacted to the challenge with a first Ca
2+ peak. More
importantly, a maintained Ca
2+ activity was rarely detected
when using ADP (Figure 6c) while a low-frequency
(≤1 min
−1) oscillatory Ca
2+ activity was detected when
cells were challenged with UTP (Figure 6d). In a fraction of
cells showing oscillatory Ca
2+ movements, a slow Ca
2+ rise
overlapped Ca
2+ oscillations (Figure 7a). When the extra-
cellular Ca
2+ dependence was tested, the slow rise of Ca
2+
disappeared in the absence of extracellular Ca
2+ while the
fraction of cells showing oscillatory activity did not change
(Figure 7b). These observations are compatible with Ca
2+
movements from intracellular compartments and Ca
2+
entrance as the mechanisms causing oscillatory activity
and slow Ca
2+ rise, respectively. Moreover, in the time span
evaluated (5–10 min), the frequency of oscillations seemed
to be unaffected by Ca
2+ removal, so depicting a mecha-
nism probably independent from extracellular Ca
2+. The
most probable source for Ca
2+ oscillations is the ER. To test
this hypothesis, ER were depleted by repeated challenges
with high doses of nucleotides or by pre-treatment with the
ER Ca
2+-ATPase inhibitor thapsigargin (Figure 8a, b). In
neither of the cases could a subsequent application of a low
dose of UTP trigger Ca
2+ oscillations, so confirming that
the ER was the source of Ca
2+.
Potential regulatory mechanisms of Ca
2+ oscillations
Once we ascertained the dual nature of the effect of low
doses of uracil nucleotides and the ER as the source of Ca
2+
oscillations, we wanted to investigate their possible
mechanisms of regulation. According to the previous
literature on Ca
2+ oscillations in other cell types, two
mechanisms might also apply to microglial cells: an
inhibitory mechanisms triggered by capacitative Ca
2+ influx
Figure 5 Nucleotide-induced capacitative Ca
2+ plateau. (a), (b)
Uridine 5'-triphosphate (UTP)-induced Ca
2+ transients were recorded
from control cells (left panel) and cells treated with the store-operated
Ca
2+ (SOC) channel blocker SKF96395 (30 μM). The Ca
2+ plateau
induced by UTP was abrogated by SKF96395, depicting the nature of
the plateau phase, while the Ca
2+ peak (due to Ca
2+ release) was
unaffected (n=81). (c), (d) Cross-desensitisation of he adenosine
diphosphate (ADP)- and UTP-induced responses. In the absence of
Ca
2+, a series of challenges with the same nucleotide (100 μM for
20 s) was followed by a single challenge with a different nucleotide.
Both nucleotides (ADP and UTP) very promptly caused Ca
2+
depletion since in this experiment, after two challenges Ca
2+, release
was abolished. Cross-desensitisation of responses elicited by the two
nucleotides depicts the fact that the receptors activated by the different
nucleotides share the same Ca
2+ stores (n=116−186)
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When a challenge with a low dose of UTP followed
previous application of a high dose of the same nucleotide,
to induce Ca
2+ influx, Ca
2+ oscillations were not affected
(Figure 9a). Neither the percentage of cells showing Ca
2+
oscillations (59±6% and 51±12% of the cells in control
and after UTP 100 μM, respectively) nor the frequency of
Ca
2+ oscillations (0.37±0.04 and 0.49±0.06 min
−1,i n
control and after UTP 100 μM, respectively) significantly
changed after a pre-application of 100 μM UTP. In a
further attempt to detect such regulatory mechanism, we
used the calcineurin inhibitor cyclosporin A since capaci-
tative Ca
2+ influx was shown to inhibit Ca
2+ oscillation by
a mechanism involving calcineurin [34]. Also in this case,
neither the percentage of cells showing Ca
2+ oscillations
(56±6%) nor the frequency of Ca
2+ oscillations
(0.45±0.06 min
−1) were affected. We then focused on
mitochondria as possible regulators of oscillations. To this aim,
we evaluated the effect on oscillatory activity of the mitochon-
drial uncoupler carbonyl cyanide p-(trifluoromethoxy) phenyl-
hydrazone (FCCP). After a 2- to 4-min-long pre-treatment with
this agent, to cause mitochondrial depolarisation, the percent-
age of cells showing Ca
2+ oscillations dropped to 14%,
suggesting a possible role played by mitochondria in the
establishment of Ca
2+ oscillations.
Discussion
With this study, we wanted to contribute to the understand-
ing of metabotropic P2 receptor signalling in microglia by
offering our description of P2Y receptor expression pattern,
by depicting some of the features of their signalling and by
focusing on the role of agonist availability on the pattern of
the Ca
2+ signals.
Molecular and functional expression profile
of P2Y receptors
Since the first electrophysiological reports on microglial
cells, nucleotides are known to stimulate both ionotropic and
metabotropic receptors. According to these first studies,
activation of the former caused inward currents and depola-
risation of membrane potential and activation of the latter
Figure 6 Different patterns of
Ca
2+ signals are induced by high
compared to low concentrations
of nucleotides. (a), (b) Long-
lasting challenges with a high
dose of nucleotides [adenosine
diphosphate (ADP) and uridine
5'-triphosphate (UTP): 100 μM
for (2–5 min) were applied to
microglial cells. The exemplify-
ing Ca
2+ traces depict the fast
Ca
2+ increase followed by a
long-lasting and slowly decay-
ing Ca
2+ plateau caused by both
nucleotides (left panel: ADP;
right panel: UTP). C, D Long-
lasting challenges with low
doses of nucleotides (ADP and
UTP: 300 nM for 5–10 min)
were applied to microglial cells.
As depicted by the exemplifying
Ca
2+ traces, ADP triggered a
single Ca
2+ peak (c) while UTP
caused a long-lasting oscillatory
Ca
2+ activity (d)
612 Purinergic Signalling (2006) 2: 605–617induced a K
+ outward current and Ca
2+ release [36–38].
Since then, several insights have been added to the picture of
P2 receptor signalling in microglial cells, contributing to
delineate a complex array of possible functions. Neverthe-
less, focused studies on receptor expression, especially of
P2Y metabotropic receptors, were missing. Only recently an
exhaustive picture of P2 receptor expression in microglia was
published, thanks to the work by Verderio and collaborators
[39]. Our description of the P2Y receptor profile diverges
from the one proposed in the above article for the presence
of functional P2Y1 and P2Y14 receptors, which we did not
detect in our study. P2Y1 and P2Y12 receptors were found to
co-exist in platelets and both to concur to the control of
platelet aggregation [40]. Based on the insensitivity to
MRS2179 and on the PTx-induced inhibition of the Ca
2+
signal induced by ADP, we depicted P2Y12 rather than P2Y1
receptors as the ones responsible for the Ca
2+ transients
elicited by ADP stimulation. However, we cannot exclude a
slight expression of the mRNA coding the P2Y1 receptor.
Moreover, as already suggested [39], we depicted the capa-
bility of P2Y12 receptors to move Ca
2+ by a mechanism that
we describe as PTx sensitive. These aspects of P2Y12
signalling are particularly interesting if we consider the role
these receptors play in microglial chemotaxis induced by
adenine nucleotides [23] and the observation that microglia
are the only cells belonging to the monocyte/macrophage
lineage that express P2Y12 receptors [41]. If this holds true,
P2Y12 receptors could be the only specific marker distinguish-
ing microglia from peripheral macrophages so far identified.
Regarding P2Y14 receptors, we found mRNA expression
by PCR but did not detect any Ca
2+ response when using
the endogenous agonist UDP-glucose. Nevertheless, since
P2Y14 receptors are known to activate Gi/o proteins [42],
we cannot exclude that the receptor proteins, if expressed,
are able to accomplish other functions, such as the control
of cyclic adenosine monophosphate (cAMP) accumulation.
Interestingly, Bianco et al. [39] described the functional
capability of P2Y14 receptors as highly dependent on cell
Figure 7 Ca
2+ signal induced by low doses of uridine 5'-triphosphate
(UTP) only partially depend on the presence of extracellular Ca
2+.
(a) When challenged with a low dose of UTP, microglial cells reacted
with Ca
2+ signals with the following patterns: a single Ca
2+ peak, an
oscillatory Ca
2+ activity and an oscillatory Ca
2+ activity superimposed
toaslowly raisingCa
2+ plateau. (b) Different populations of microglial
cells were challenged with UTP 300 nM in the presence or absence of
Ca
2+, and the percentage of cells reacting with the different patterns of
Ca
2+ signals was calculated (n=198−247). The absence of Ca
2+ did
not affect the percentage of occurrence of the single peak nor of the
oscillatory activity while completely abrogated the slow rise of Ca
2+
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promotes P2Y14 protein expression or coupling of the
receptor to Ca
2+ release. We should also consider that
culture conditions slightly differing from lab to lab make it
illusory to have a completely overlapping picture of a
complex signalling system such as the P2Y, even more so
in plastic cells such as microglia. Moreover, we found it
interesting to consider some other aspects as causes of
difference. Among these, the areas of the brain from which
cell cultures come (cortex versus hippocampus), the
developmental phase (embryonic versus post-natal) and
species differences (rat versus murine N9 cell line). All of
these aspects should be considered as interesting topics for
further, more focused, investigations.
Ca
2+ responses induced by adenine
versus uracil nucleotides
According to our data, the Ca
2+ signals triggered by
adenine and uracil nucleotides differ from two main
aspects: the main G protein involved and the more efficient
induction of capacitative influx by uracil nucleotides. We
utilised ADP to activate P2Y receptors sensitive to adenine
Figure 8 Oscillatory Ca
2+ activity is abrogated by depleting Ca
2+
from the endothelial reticulum (ER) stores. (a), (b) Ca
2+ depletion
from the ER stores was achieved by a repetitive receptor activation (a)
or by applying the sarcoplasmic/endoplasmic reticulum calcium
ATPase (SERCA) inhibitor thapsigargin (b) in the absence of Ca
2+.
Following a series of applications of uridine 5'-triphosphate (UTP)
100 μM or a 2-min-long treatment with thapsigargin (100 nM),
300 nM UTP was applied to microglial cells. The exemplifying Ca
2+
traces show the absence of oscillatory activity following endothelial
reticulum (ER) Ca
2+ depletion (n=60−94)
Figure 9 Oscillatory Ca
2+ activity is regulated by mitochondrial
“energy charge” but not by a previous activation of the capacitative
influx. (a) To point out the eventual regulatory role on Ca
2+
oscillations of a high dose of uridine 5'-triphosphate (UTP), an
application of 100 μM of the nucleotide was applied prior to an
application of 300 nM of the same nucleotide. As depicted by the
exemplifying Ca
2+ signals, Ca
2+ oscillatory activity did not differ from
that recorded from non-pre-treated cells (n=64). (b) To evaluate the
regulatory role of calcineurin activated by a previous Ca
2+ influx
through capacitative channels, an application of 100 μM UTP was
followed by an application of 300 nM of the same nucleotide in the
presence of the calcineurin inhibitor cyclosporin-A (1 μM). Also in
this case, the oscillatory Ca
2+ activity was not affected (n=90). (c) To
evaluate the regulatory role of mitochondrial activity on oscillatory
Ca
2+ activity, microglial cells were treated with the mitochondrial
uncoupler carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone
(FCCP) (2 μM for 3 min) prior to 300 nM UTP. As shown by the
exemplifying Ca
2+ traces, FCCP pre-treatment completely abrogated
UTP-induced oscillatory Ca
2+ activity, suggesting the involvement of
mitochondria in the regulation of the oscillatory Ca
2+ activity
(n=273)
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Ca
2+ release occurred by a PTx-dependent mechanism
while UTP-induced Ca
2+ signals were almost unaffected by
PTx pre-treatment. Involvement of different G proteins
determined an early divergence of signal transduction
pathways following receptor and G protein activation. In
the case of uracil nucleotides, known to act mainly on
Gq/11 and here found to be only partially PTx sensitive,
Gα subunit would trigger PLC+ activation and Ca
2+
release through IP3 receptor/channels [43]. In the case of
P2Y12 receptors activated by ADP, the Gβγ subunit would
trigger PLCβ activation and Ca
2+ release while the Gαi
subunit would probably cause a concomitant inhibition of
adenylyl cyclase and cAMP reduction. However, even if the
signalling pathways are so different, they converge to the
same ER stores that the two nucleotides, when used at a
concentration of 100 μM, deplete with similar efficacy, as
depicted by cross-desensitisation experiments. This bring us
to the other difference between the Ca
2+ signalling induced
by the two receptor types. Depletion of Ca
2+ from the ER
stores is known to be the starting signal of induction of the
capacitative Ca
2+ influx mainly described in non-excitable
cells, among them microglia [21]. The nature and identity
of the agent (or event) following Ca
2+ depletion is still a
matter of debate, and it might also be that different
mechanisms put in place by ER Ca
2+ depletion act in
different cells [44]. In any case, in microglial cells, Ca
2+
depletion might be necessary but certainly is not sufficient
to cause capacitative Ca
2+ influx. As already shown [21],
uracil nucleotides (UTP and UDP) were clearly more
efficient than ADP in inducing the Ca
2+ plateau, which
we identified as being due to capacitative influx on the
basis of the sensitivity to SKF96395 and extracellular Ca
2+.
Regardless the mechanisms utilised, the capability to
trigger capacitative Ca
2+ influx adds further functional
capability to the receptors sensitive to uracil nucleotides, as
depicted by the specificity of some functional outcomes
linked to capacitative influx besides ER Ca
2+ store
replenishment: examples of this specificity are the modu-
lation of some Ca
2+-dependent adenylyl cyclase isoforms
[45] and Ca
2+-calmudulin-induced activation of nuclear
factor of activated T cells (NFAT), which specifically need
capacitative Ca
2+ [44].
Oscillatory Ca
2+ activity induced by low doses
of nucleotides
The release of nucleotides can occur not only following cell
lysis but also by highly regulated mechanisms in the course
of cell activity, such as action potential propagation,
synaptic activity and astrocytic Ca
2+ waves [13, 27]. Can
the different availability of nucleotides for receptor activa-
tion be utilised by microglia as an indicator of the condition
of the host tissue? To address this question, we compared
the Ca
2+ signals triggered by P2Y receptors activated by
long-lasting applications of low versus high doses of
nucleotides. When ADP was applied at a low dose, only a
single peak of Ca
2+ was observed in a fraction of cells. On
the contrary, when a low dose of UTP was used, we
observed a more complex behaviour markedly differing
from that induced by a high dose of the nucleotide: while
this latter induced a single event of release followed by a
long-lasting and slowly decaying phase of capacitative
influx, a low dose of UTP (also of UDP: data not shown)
caused an oscillatory Ca
2+ activity only rarely super-
imposed to a slowly rising Ca
2+ influx. Our data do not
allow identification of a link between oscillatory release
and Ca
2+ influx, but we cannot exclude that oscillatory
activity sustained for a time span longer than our experi-
ments would need the contribution of Ca
2+ influx. In recent
years, a non-capacitative Ca
2+ influx pathway elicited by
low doses of metabotropic agonists, depending on arachi-
donic acid and responsible for the maintainence of Ca
2+
oscillation, was described in a number of cells [46].
Moreover, calcineurin activation by capacitative Ca
2+ entry
was shown to inhibit the non-capacitative entry [34].
However, we did not detect any regulatory role played by
a high dose of UTP or by the calcineurin inhibitor
cyclosporin-A on the oscillatory Ca
2+ activity.
An increasing body of evidence supports the relation-
ship between cytoplasmic and mitochondrial Ca
2+
changes [47, 48]. Energised mitochondria are known to
take up Ca
2+ accumulated in the cytoplasm, mainly thanks
to the mitochondrial uniporter, and to release it back by the
Na
+/Ca
2+ exchange system. Not only can mitochondria
function as Ca
2+ buffers, they also utilise the ion to regulate
their own activity since the F1F0-ATP synthase and a
number of mitochondrial dehydrogenases are regulated by
Ca
2+. It was suggested that mitochondria could increase the
release of Ca
2+ from IP3R channels by rapidly removing
Ca
2+ from their mouth, so decreasing Ca
2+-induced
inactivation of the channels. The Ca
2+ taken by mitochon-
dria could be recycled back to the Ca
2+ ATPase on the ER
to allow prompt refilling of the stores [49]. This would
finally maintain the efficiency of the release process. When
we utilised the protonophore FCCP, known to cause
mitochondrial depolarisation, we could clearly see a
decrease of oscillatory Ca
2+ release induced by low doses
of UTP. Interestingly, FCCP did not affect the potent
release induced by a high dose of UTP (data not shown), as
if for long-lasting oscillatory activity to occur in the
presence of low IP3 synthesis a fine regulation of
cytoplasmic Ca
2+ was needed to maintain IP3R channels
available to open. This is one of the first indications of the
involvement of mitochondria in the control of cytoplasmic
Ca
2+ changes in microglia, and further investigation is
Purinergic Signalling (2006) 2: 605–617 615needed to come to an unambiguous interpretation of this
result since FCCP can have a number of outcomes together
with the decrease of Ca
2+ uptake by mitochondria, such as
ATP depletion and pH changes. In any case, it is
noteworthy that during microglia activation, mitochondria
change their cellular distribution, morphology and internal
organisation, probably to better sustain energy-consuming
functions of activated microglia [50].
In this study, we pointed out the capability of P2Y
receptors to cause different patterns of cytoplasmic Ca
2+
changes involving capacitative Ca
2+ influx and intracellular
Ca
2+ mobilisation, depending not only on the type but also
on the concentration of the agonist. Intracellular Ca
2+
changes can independently affect a multitude of functions
and events depending on the vicinity of the Ca
2+ sources to
specific target proteins, on the concentration reached and
also on the time evolution of the Ca
2+ variations. It is
known that sustained and oscillatory Ca
2+ changes can
differently affect target proteins (for a review, see 51).
Protein kinases, phospholipases and transcription factors
are examples of the multitude of proteins that can be
differently regulated by Ca
2+.
In conclusion we speculate that the different patterns
of Ca
2+ signals elicited by different concentrations of
nucleotides would render P2Y receptors capable of signal-
ling to microglia the state of the host tissue and, hopefully,
regulate microglial responses in concert with the needs of
the tissue.
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